Less Direct Patient Care for Fellowship-Trained Pediatricians

This article originally appeared here.
Share this content:
Less Direct Patient Care for Fellowship-Trained Pediatricians
Less Direct Patient Care for Fellowship-Trained Pediatricians

TUESDAY, Sept. 8, 2015 (HealthDay News) -- Generalist-trained pediatricians have more schedule flexibility and work fewer hours than fellowship-trained pediatricians, although both groups report overall satisfaction with their careers, according to a study published online Sept. 7 in Pediatrics.

Bobby J. Byrne, M.D., from Indiana University in Indianapolis, and colleagues analyzed national, weighted data from 842 pediatricians eight to 10 years after residency. The authors compared work environment, work-life balance, and satisfaction for pediatricians who had pursued fellowship training (39 percent) and those who had not pursued fellowship training (generalist-trained).

The researchers found that, compared with the generalist-trained group, the fellowship-trained group was less likely to spend time in direct patient care and more likely to report learning opportunities in their work environment. Fellowship-trained pediatricians were more likely to report an income of ≥$150,000, although there was no difference seen on examination of full-time pediatricians only. The likelihood of working fewer than 50 hours per week, having flexibility with their schedules, and being satisfied with the time spent with their own children was higher for generalist-trained pediatricians. In both groups, pediatricians found their work to be rewarding and were satisfied with their lives.

"Although residents need to consider important life and career differences when contemplating fellowship training and general care, pediatricians in both groups can achieve overall life and career satisfaction," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters




More in Home

FDA Approves Palynziq for Phenylketonuria

FDA Approves Palynziq for Phenylketonuria

Drug is a novel enzyme therapy for adult patients with PKU with uncontrolled blood Phe concentrations

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in proportion of adults recommended for treatment; estimated decrease in CVD events, deaths